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Abstract
Background: Epithelial to mesenchymal transition (EMT) induced by hypoxia is one of the critical causes of treatment failure
in different types of human cancers. NF-kB is closely involved in the progression of EMT. Compared with HIF-1a, the
correlation between NF-kB and EMT during hypoxia has been less studied, and although the phenomenon was observed in
the past, the molecular mechanisms involved remained unclear.
Methodology/Principal Findings: Here, we report that hypoxia or overexpression of hypoxia-inducible factor-1a (HIF-1a)
promotes EMT in pancreatic cancer cells. On molecular or pharmacologic inhibition of NF-kB, hypoxic cells regained
expression of E-cadherin, lost expression of N-cadherin, and attenuated their highly invasive and drug-resistant phenotype.
Introducing a pcDNA3.0/HIF-1a into pancreatic cancer cells under normoxic conditions heightened NF-kB activity,
phenocopying EMT effects produced by hypoxia. Conversely, inhibiting the heightened NF-kB activity in this setting
attenuated the EMT phenotype.
Conclusions/Significance: These results suggest that hypoxia or overexpression of HIF-1a induces the EMT that is largely
dependent on NF-kB in pancreatic cancer cells.
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Introduction
Pancreatic cancer, which is one of the most aggressive and lethal
cancers worldwide, is highly resistant to chemotherapy [1]. Even
systemic therapy with gemcitabine, a current first-line treatment
for advanced pancreatic cancer offers only modest benefit due to
intrinsic or acquired chemoresistance [2,3]. Further, recent clinical
studies indicate that only 12% of patients with advanced
pancreatic cancer have a response to gemcitabine [4]. The poor
response rate suggests that pancreatic cancer either rapidly
develops or has gemcitabine chemoresistance. The mechanisms
by which chemoresistance arises in pancreatic cancer are
unknown; thus a better understanding of how resistance arises
and what molecular alterations cause or correlate with resistance is
likely to lead to novel therapeutic strategies for pancreatic cancer.
Hypoxia is an environmental stimulus that plays a key role in
development and cancer progression. Tumoral hypoxia or
expression HIF-1 (hypoxia-inducible factor-1) has been linked to
an aggressive phenotype which correlates with a poor response to
chemotherapy and a worse overall survival of cancer patients
[5,6]. HIF-1 is a heterodimeric protein consisting of HIF-1b,a
constitutively expressed subunit, and HIF-1a, an oxygen-sensitive
inducible subunit. Under normoxic conditions, HIF-1a protein is
hydroxylated by a family of oxygen-dependent prolyl hydroxylases
(PHD1–3); this targets it for polyubiquitination by a protein
complex containing von Hippel-Lindau protein (pVHL) and then
degradation. Under hypoxic conditions, prolyl hydroxylases are
inactivated, and HIF-1a degradation is blocked; this allows HIF-
1a to accumulate and associate with HIF-1b to form a functional
transcription complex that triggers the transcription of a host of
hypoxia-inducible genes [7].
Epithelial to mesenchymal transition (EMT) is the process by
which adherent epithelial cells convert to motile mesenchymal
cells and is essential in embryonic development. EMT is now
known to also occur in a variety of diseases including the
progression of cancer [8]. In the recent study, evidence is provided
suggesting that moderate hypoxic conditions can trigger, as an
independent factor, an EMT programme leading different human
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some studies also reported that activation of NF-kB is closely
involved in the progression of EMT [10–13]. Detailed examina-
tions of the multiple facets of the EMT program have revealed its
involvement in more than just invasion and metastasis; recent
studies showed that the phenotype of EMT is associated with
chemoresistance in diverse solid tumors [14–17].
Nuclear factor-kappa B (NF-kB) represents a family of
transcription factors that modulate expression of genes with
diverse functions. The activity of NF-kB is regulated by the NF-kB
inhibitory protein (IkB), that binds to and sequesters NF-kB family
members in the cytoplasm. When the NF-kB pathway is activated,
IkB is phosphorylated by IkB kinase (IKK), which phosphorylates
IkB. Phosphorylated IkB is subjected to ubiquitination and
proteasome-mediated degradation, which results in the transloca-
tion of NF-kB to the nucleus. NF-kB is a ubiquitous transcription
factor regulated by many stimuli including hypoxia, cytokines and
chemotherapeutic drugs, and has recently emerged as a target for
cancer. NF-kB is constitutively activated in most human
pancreatic cancer cells and primary tumor specimens, but not in
normal pancreatic tissues or nontumorigenic cell lines [18–20].
Some recent studies showed that hypoxia can activate NF-kB and
induce resistance of pancreatic cancer cells to gemcitabine [21–
23]. Previously, we reported that using Dihydroartemisinin or
small interfering RNA (siRNA) inactivates NF-kB and potentiates
the antitumor effect of gemcitabine on pancreatic cancer both in
vitro and in vivo [24,25].
In this study, we sought evidences that pancreatic cancer cells
(PANC-1, BxPC3) under hypoxic conditions undergo the process
of EMT and acquire invasive and drug-resistant phenotypes in a
NF-kB–dependent fashion. Herein, we demonstrated that hypoxia
or overexpression of HIF-1a activated NF-kB and promoted EMT
in pancreatic cancer cells. On molecular or pharmacologic
inhibition of NF-kB, hypoxic cells regained expression of E-
cadherin, lost expression of N-cadherin, and attenuated their
highly invasive and drug-resistant phenotype. Introducing a
pcDNA3.0/HIF-1a into pancreatic cancer cells under normoxic
conditions heightened NF-kB activity, phenocopying EMT effects
produced by hypoxia. Conversely, inhibiting the heightened NF-
kB activity in this setting reversed the EMT phenotype. Taken
together, these results suggest that hypoxia or overexpression of
HIF-1a induce the EMT that is largely dependent on NF-kBi n
pancreatic cancer cells.
Results
Hypoxia results in the morphologic and cell biological
changes characteristic of EMT in pancreatic cancer cells
To recapitulate the effects of hypoxia as it occurs in pancreatic
cancer, we exposed 55–60% subconfluent pancreatic cancer cells
(PANC-1, BxPC-3) to hypoxic conditions (1% O2,5 %C O 2, and
94% N2) up to 48 h. We observed marked differences in the
morphology and tendency to form cellular nests or clusters
between the pancreatic cancer cells under hypoxic conditions and
their normoxic counterparts (95% air and 5% CO2). The
normoxic cells exhibited a polygonal shape and cobblestone-like
sheets, indicative of an epithelial phenotype. In contrast, the
hypoxic cells started to loose cell contacts, scattered from cell
clusters and acquired a elongated, fusiform morphology with
dendritic processes, consistent with a mesenchymal transition
(Fig. 1B).
To confirm whether pancreatic cancer cells underwent EMT
exposed to hypoxia, we also determined the expression of markers
of epithelial and mesenchymal phenotypes by Western blot
analysis. As shown in Fig. 1A, hypoxic cells underwent a ‘‘cadherin
switch,’’ whereby they manifested reduced E-cadherin expression
and increased N-cadherin expression. In addition, the expression
of HIF-1a, an important marker of hypoxia pathway, was found
intensely expressed under hypoxic condition for 48 h (Fig. 1A).
Immunofluorescence staining was employed to further confirm
EMT phenotype changes of pancreatic cancer cells under hypoxic
condition. It was shown that the expression of E-cadherin
decreased and the expression of Vimentin increased when
compared with those in normoxic cells (Fig. 1C).
Cancer cells that have undergone EMT tend to exhibit greater
drug resistance and invasiveness. As such, we examined these
properties in normoxic cells versus hypoxic cells in Cell Counting
Kit-8 assay, Crystal violet assay and Matrigel invasion assay.
Striking differences were observed. Cell Counting Kit-8 assay was
used to assess the cell viability rate. PANC-1 and BxPC-3 cells
were exposed to gradient doses of gemcitabine (0–200 mmol/L) for
48 h. Data are shown in Fig. 1D, when treated with concentration
of gemcitabine larger than 100 nmol/L, hypoxic cells showed
significantly higher cell viability rate than the normoxic cells.
These results were further confirmed by Crystal violet assay
(Fig. 1E), when cells were treated with gemcitabine (10 mmol/L for
PANC-1 and 500 nmol/L for BxPC-3) under hypoxic or
normoxic conditions for 48 h, hypoxic cells showed significantly
higher cell viability rate than normoxic cells. Matrigel invasion
assay was used to assess the cell invasiveness. Both PANC-1 and
BxPC-3 cells under hypoxic conditions for 48 h readily migrated
through the Matrigel chamber in relatively high numbers, whereas
their normoxic partners exhibited a marked reduction in invasion
(Fig. 1F).
Taken together, our data indicating changes in morphology,
growth pattern, protein expression, drug resistance and invasion
support the notion that hypoxia leads to EMT in pancreatic
cancer cells.
Pancreatic cancer cells under hypoxic conditions exhibit
heightened NF-kB activity
Some studies have previously shown that hypoxia results in
activation of NF-kB [19,20]. Thus, we sought to determine
whether the EMT observed in pancreatic cancer cells under
hypoxic conditions was attributable to heightened NF-kB activity.
First, we documented that NF-kB p65 proteins and NF-kB DNA
binding activity were indeed increased in hypoxic pancreatic
cancer cells compared with the normoxic counterparts as
determined by Western blot analysis and EMSA. Meanwhile,
HIF-1a was also analyzed by Western blot analysis (Fig. 2A).
PANC-1 and BxPC-3 cells were incubated under hypoxic
conditions for different periods of time (24 h, 48 h, 72 h). After
each indicated incubation period, the cells were collected, and
total or nuclear proteins were extracted. As shown in Fig. 2A and
B, NF-kB p65 proteins and NF-kB DNA binding activity were
increased 24 h after initiation of hypoxia and maintain high levels.
The specificity of gel-shifted bands in the EMSA was documented
by cold competition experiments, in which excess cold wild-type
but not cold mutant kB probe abrogated the signals from the
shifted bands.
Meanwhile, HIF-1a was also analyzed by Western blot analysis.
As shown by Western blotting (Fig. 2A), HIF-1a protein levels in
pancreatic cancer cells were up-regulated during hypoxia. The
increase in HIF-1a protein level was possibly due to protein
stability effects as studied previously [7]. Since the expression of
HIF-1a target gene VEGF, a growth factor that can promote
EMT, is mediated by NF-kB, we also determine whether hypoxia
stimulates VEGF expression. As shown in Fig. 2C, Western
EMT Induced by Hypoxia in Pancreatic Cancer Cells
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cantly after 24 h of hypoxia and maintained high levels. By
contrast, the up-regulation of VEGF was suppressed by silencing
NF-kB p65 expression in hypoxic pancreatic cancer cells using the
NF-kB p65-specific siRNA, while no effect was seen in cells
transfected with the control siRNA (Fig. 2D).
Inhibition of NF-kB activity in pancreatic cancer cells
under hypoxic conditions mediates EMT
Having established that hypoxia results in elevated NF-kB
activity in pancreatic cancer cells, we next investigated the
potential for inhibition of NF-kB to attenuate the mesenchymal
characteristics of hypoxic cells. Toward this end, we used both
molecular and pharmacologic means of inhibiting NF-kB in these
hypoxic cells and then compared the resulting phenotype with
control-treated cells. Molecular inhibition was accomplished by
siRNA to downregulate the p65 subunit of NF-kB. We also used a
commercially available IKK inhibitor BAY 11-7082 to pharma-
cologically block NF-kB activity. Inhibition of NF-kB activity by
either the NF-kB p65 siRNA or BAY 11-7082 under hypoxic
conditions for 48 h resulted in a change in protein expression
characterized by increased E-cadherin and reduced N-cadherin
expression as determined by Western blot analysis (Fig. 3A),
consistent with reversion to an epithelial phenotype. Importantly,
inhibition of NF-kB by either NF-kB p65 siRNA or BAY 11-7082
led to a marked decrease in the invasiveness of hypoxic cells
compared with control treated cells in Matrigel invasion assay
under hypoxic conditions for 48 h (Fig. 3B). When cells were
treated with gemcitabine (10 mmol/L for PANC-1 and 500 nmol/
L for BxPC-3) for 48 h with inhibition of NF-kB activity by either
NF-kB p65 siRNA or IKK inhibitor under hypoxic conditions,
they also showed significantly lower viability rate than their
respective controls in Crystal violet assay (Fig. 3C) and Cell
Counting Kit-8 assay (Fig. 3D). Despite these changes in protein
expression, invasiveness and drug resistance attributable to NF-kB
blockade, we did not observe any profound changes in the
morphology or growth patterns of pancreatic cancer cells under
hypoxic conditions, an observation that implicates NF-kB–
independent biochemical events that also contribute to the EMT
phenotype in hypoxic pancreatic cancer cells.
Pancreatic cancer cells under hypoxic conditions exhibit
NF-kB–dependent upregulation of Twist, transcriptional
regulators of the EMT program
The gene expression program that mediates EMT is regulated
by one or more transcription factors, including Twist, Zeb1, Zeb2,
and Snail [26]. These transcription factors influence the expression
of cadherins and metalloproteinases, among other proteins
involved in EMT. That these transcription factors are transcrip-
tionally induced by upstream signaling pathways, including NF-kB
[26], prompted us to observe their differential expression in
pancreatic cancer cells under hypoxic conditions versus normoxic
conditions by Western blot analysis. Hypoxic pancreatic cancer
cells exhibited substantial upregulation of Twist, Snail, Zeb1, and
Zeb2 as compared with normoxic cells (Fig. 4A). Pharmacologic
inhibition of IKK by BAY 11-7082 in hypoxic cells resulted in a
dose-dependent decrease in Twist expression but no notable
changes in Zeb1, Zeb2 or Snail expression, a finding that indicts
the heightened state of NF-kB as an etiologic biochemical force
underlying Twist overexpression in pancreatic cancer cells under
hypoxic conditions (Fig. 4B). These findings indicate that the
augmented expression of Twist that occurs in the setting of
pancreatic cancer cells under hypoxic conditions is mediated by
heightened NF-kB activity.
Overexpression of HIF-1a in pancreatic cancer cells under
normoxic conditions induces EMT in NF-kB–dependent
manner
Recent reports have established an etiologic link between HIF-
1a expression to suppression of E-cadherin and acquisition of a
mesenchymal phenotype [27]. Thus, we hypothesized that the
EMT that pancreatic cancer cells undergo in response to HIF-1a
expression occurs, at least in part, due to the HIF-1a-mediated
activation of the NF-kB pathway. First, we transiently introduced
a pcDNA3.0/HIF-1a into PANC-1 under normoxic conditions
(HIF-1a
+/N) using a LipofectamineTM 2000. Whereas HIF-1a
was almost undetectable in PANC-1 under normoxic conditions
transduced with control empty vector (pcDNA3.0/N), the HIF-1a
levels in HIF-1a
+/N cells were comparable with those in the cells
under hypoxic conditions for 48 h (Fig. 5A). Next, we confirmed
that NF-kB activity did in fact increase in these HIF-1a
+/N cells
than pcDNA3.0/N cells. Indeed, HIF-1a
+/N cells exhibited
heightened NF-kB activity as determined by Western blot analysis
and EMSA (Fig. 5A and B).
Having established that HIF-1a
+/N cells manifest heightened
NF-kB activity, we next assessed these cells for evidence of EMT.
Compared with pcDNA3.0/N cells, HIF-1a
+/N cells exhibited an
increase in N-cadherin expression and suppression of E-cadherin
under normoxic conditions for 48 h as determined by Western
blot analysis (Fig. 6A). Immunofluorescence staining was employed
to further confirm an EMT induced by HIF-1a under normoxic
conditions, the expression of E-cadherin decreased and Vimentin
increased in the HIF-1a
+/N cells compared with pcDNA3.0/N
cells under normoxic conditions for 48 h (Fig. 6B). This cadherin
switch was also associated with increased Twist, Snail, Zeb1, and
Zeb2 expression (Fig. 6A), findings that are reminiscent of those
observed in pancreatic cancer cells under hypoxic conditions
(Fig. 4A). The role of NF-kB in modulating these protein
expression changes was illustrated by the effects of inhibition of
NF-kB in HIF-1a
+/N cells by exposure to the IKK inhibitor BAY
11-7082 (0–10 mmol/L), which reversed the cadherin switching
phenomenon as well as reduced the expression of Twist in a dose-
dependent but no notable changes in Zeb1, Zeb2 or Snail
Figure 1. Hypoxia induces EMT phenotype in pancreatic cancer cells. (A) Western blot analysis of epithelial marker (E-cadherin) and
mesenchymal markers (Vimentin, N-cadherin) and HIF-1a of PANC-1, BxPC-3 cells under normoxic (N) or hypoxic (H) conditions for 48 h. A
representative blot from three independent experiments was shown. The histogram showed the average volume density corrected for the loading
control (b-actin). *, p,0.05. (B) Phase contrast analysis (original magnification, 6100) of morphological changes detected in pancreatic cancer cells
under normoxic or hypoxic conditions for 48 h. (C) Immuofluorescence staining of E-cadherin and Vimentin in PANC-1, BxPC-3 cells under normoxic
or hypoxic conditions for 48 h. Green represents E-cadherin staining, whereas red represents Vimentin staining. Blue signal represents nuclear DNA
staining by DAPI. (D) The viability of cells was assessed by the Cell Counting Kit-8 assay and used to calculate the viability index. PANC-1 and BxPC-3
cells were exposed to gemcitabine (0 mmol/L) for 48 h as the baseline. *, p,0.05. (E) The proliferation of cells was measured by crystal violet assay.
Figures were selected as representative scenes from three independent experiments. (F) Matrigel invasion assay. Left, photomicrographs of cells that
have passed through Matrigel under normoxic or hypoxic conditions for 48 h (original magnification, 6100). Right, quantification of invasion.
*, p,0.05.
doi:10.1371/journal.pone.0023752.g001
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1a
+/N cells and its dependence on heightened NF-kB activity
were evaluated in Matrigel invasion assay, Crystal violet assay and
Cell Counting Kit-8 assay. For example, invasiveness of HIF-1a
+/
N cells through a Matrigel chamber was significantly greater than
that of pcDNA3.0/N cells under normoxic conditions for 48 h
(Fig. 6D). Similarly, when cells were treated with gemcitabine
(10 mmol/L) for 48 h under normoxic conditions, significantly
higher cell viability rate was showed in HIF-1a
+/N cells compared
with pcDNA3.0/N cells as determined by Crystal violet assay
(Fig. 6E) and Cell Counting Kit-8 assay (Fig. 6F). The enhanced
invasion and gemcitabine resistance of HIF-1a
+/N cells were
Figure 2. Hypoxia induced HIF-1a and NF-kB overexpression in pancreatic cancer cells. PANC-1 and BxPC-3 cells were cultured under
normoxic (N) or hypoxic conditions (H) for various periods (24 h, 48 h, 72 h). After each indicated incubation period, the cells were collected. Nuclear
extracts and total protein extracts were prepared. (A) NF-kB p65 and HIF-1a were analyzed by Western blot analysis from respective cell homogenate.
The histogram showed the average volume density corrected for the loading control (b-actin). *, p,0.05. (B) EMSA for NF-kB DNA-binding activity on
respective nuclear extracts. Competitive assay confirmed the specificity of NF-kB binding to the DNA (see Materials and methods for details). Right
two lanes, wt, wild-type; m, mutant. (C) VEGF was analyzed by Western blot analysis from respective cell homogenate. The histogram showed the
average volume density corrected for the loading control (b-actin). *, p,0.05. (D) Western blot analysis. Effects of the NF-kB p65 siRNA on VEGF
expression of PANC-1 and BxPC-3 cells under hypoxic conditions for 48 h. The histogram showed the average volume density corrected for the
loading control (b-actin). *, p,0.05.
doi:10.1371/journal.pone.0023752.g002
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inhibitor BAY 11-7082 (10 mmol/L) under normoxic conditions
for 48 h (Fig. 6D, E and F). Thus, the augmentation in
invasiveness and gemcitabine resistance in PANC-1 that are
typified by hypoxia occurs as a result of activation of the NF-kB
pathway induced by HIF-1a.
Figure 3. Inhibition of NF-kB reverses EMT characteristics in pancreatic cancer cells under hypoxic conditions. (A) Western blot
analysis. Effects of the NF-kB p65 siRNA and IKK inhibitor BAY 11-7082 on N-cadherin and E-cadherin expression of PANC-1 and BxPC-3 cells under
hypoxic conditions for 48 h. The histogram showed the average volume density corrected for the loading control (b-actin). *, p,0.05. (B) Matrigel
invasion assays. Left, photomicrographs after cells were treated with NF-kB p65 siRNA or BAY 11-7082 (10 mmol/L) or appropriate respective controls.
Original magnification, 6100. Right, quantification of invasion assay. *, p,0.05. (C) The proliferation of cells was measured by Crystal violet assay.
Figures were selected as representative scenes from three independent experiments. (D) The viability of cells was assessed by the Cell Counting Kit-8
assay and used to calculate the viability index. *, p,0.05.
doi:10.1371/journal.pone.0023752.g003
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activity. (A) Western blot analysis of baseline expression of EMT-mediating transcription factors: Twist, Snail, Zeb1, and Zeb2 in pancreatic cancer
cells under normoxic (N) versus hypoxic (H) conditions for 48 h. The histogram showed the average volume density corrected for the loading control
(b-actin). *, p,0.05. (B) Western blot analysis. Dose-dependent effects of a 48-h exposure of the IKK inhibitor BAY 11-7082 on expression of Twist,
Snail, Zeb1, and Zeb2 under hypoxic conditions. A representative blot from three independent experiments was shown. The histogram showed the
average volume density corrected for the loading control (b-actin).
doi:10.1371/journal.pone.0023752.g004
Figure 5. Overexpression of HIF-1a in pancreatic cancer cells under normoxic conditions induces NF-kB activation. (A) Western blot
analysis of NF-kB p65 and HIF-1a expression of PANC-1 cells under hypoxic conditions for 48 h (H/48 h), PANC-1 cells transduced with pcDNA3.0
empty vector (pcDNA3.0/N) and pcDNA3.0/HIF-1a (HIF-1a
+/N) under normoxic conditions for 48 h. The histogram showed the average volume
density corrected for the loading control (b-actin). *, p,0.05. (B) EMSAs for NF-kB DNA-binding activity in H/48 h, HIF-1a
+/N, and pcDNA3.0/N PANC-1
cells. Right two lanes, cold competition EMSA.
doi:10.1371/journal.pone.0023752.g005
EMT Induced by Hypoxia in Pancreatic Cancer Cells
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In recent years, it has become increasingly clear that EMT plays
important roles in the progression of cancer and is also responsible
for the resistant phenotype of cancer cells to conventional
chemotherapeutics [8]. Various factors, including hypoxia, have
been indicted as inducing this phenomenon through induction of
Twist, Snail, Zeb1, and Zeb2 depending on the cellular contexts
[11,26–28]. A hypoxic microenvironment is commonly found in
the central region of solid tumors. The connection between
hypoxia and EMT has been previously reported, and HIF-1a has
been indicted as mediating this phenomenon. However, the
molecular underpinnings of HIF-1a-induced up regulation of
these EMT-inducing transcription factors have been largely
undefined, although evidence in support of the ability of HIF-1a
to directly induce Twist transcription has been recently described
in human embryonic kidney cells [27].
Previous study showed that hypoxia lead to NF-kB activation
and such activation was mediated by phosphorylation of IkBa on
tyrosine residues [28]. NF-kB activation is a critical component in
the transcriptional response to hypoxia. Our data presented herein
indicated that NF-kB activation is increased under hypoxic
conditions as well as transiently transfected with a pcDNA3.0/
HIF-1a in pancreatic cancer cells under normoxic conditions.
Meanwhile, the heightened NF-kB activity under hypoxia is
inhibited by IKK inhibitor BAY-11-7082, which can inhibit the
phosphorylation and degradation of IkBa, and prevents the
translocation of p65/p50. Both our data and previous studies
showed that biochemical pathways leading to NF-kB activation
converged on the IKK complex under hypoxic conditions.
Recently, it was reported that NF-kB transcriptionally induces
HIF-1a expression in murine macrophages, liver, and brain [29].
We also found that pharmacologic inhibition of NF-kB, IKK
inhibitor BAY-11-7082, resulted in reduced HIF-1a expression in
both PANC-1 and BxPC-3 cells under hypoxic conditions (data
not shown). These findings suggest the existence of a biochemical
loop, whereby HIF-1a activates NF-kB and vice versa. Interrupt-
ing this loop in pancreatic cancer cells at one or more of the many
biochemical steps that link HIF-1a to NF-kB is apt to have a
significant effect on pancreatic cancer growth. However, the
relationship between HIF-1a and NF-kB in the process of tumor
development is particularly complex and requires further explo-
ration. Furthermore, we have shown that the EMT program
attributable to hypoxia or overexpression of HIF-1a is largly
driven by activation of the classic NF-kB pathway. This EMT
program is characterized by Vimentin and N-cadherin expression
and E-cadherin suppression, striking morphologic changes, a
highly invasive and gemcitabine-resistant mesenchymal pheno-
type.
The recent study showed that the expression of HIF-1a target
gene VEGF, a growth factor that can promote EMT in prostate
cancer [30]. In this study, the data also showed that protein
expression of VEGF increased significantly in pancreatic cancer
cells under hypoxic conditions and the up-regulation of VEGF,
induced by hypoxia, was abolished by NF-kB p65 siRNA. We also
found that these cells incubated under hypoxic conditions or
transfected with pcDNA3.0/HIF-1a under normoxic conditions
exhibit heightened NF-kB activity, the inhibition of which results
in reversion of the cadherin switch to that of an epithelial
phenotype typified by reduced invasion and increased gemcitabine
sensitivity, findings that implicate NF-kB as a principal mediator
of the HIF-1a-induced EMT program in pancreatic cancer cells
under hypoxic conditions.
Other studies have previously identified Zeb1, Zeb2, and Snail
as central regulators of E-cadherin suppression and EMT in
pancreatic cancer cells [11,31]. However, the expression of Twist
was not detected under normoxic conditions and the Twist gene
was activated after exposure to hypoxia in five pancreatic cancer
cell lines [32]. In this study, we showed that the EMT induced by
hypoxia or overexpression of HIF-1a was associated with
increased Twist, Snail, Zeb1, or Zeb2 expression. We also found
that pharmacologic inhibition of IKK by BAY 11-7082 in hypoxic
cells resulted in a dose-dependent decrease in Twist expression but
no notable changes in Zeb1, Zeb2 or Snail expression, which
suggests that the specific transcription factors regulating EMT
depend on the cellular context and the specific state of cells. This
mesenchymal transformation can in large part be attenuated by
inhibiting NF-kB through either molecular or pharmacologic
approaches, although NF-kB blockade does not promote a
complete reversion to an epithelial phenotype, as evidenced by
maintenance of the Snail, Zeb1, or Zeb2 expression in the face of
NF-kB p65 siRNA or IKK inhibition. This latter finding suggests
the existence of NF-kB–independent EMT regulatory pathways in
pancreatic cancer cells under hypoxic conditions that remain to be
defined. In view of all of these EMT-modulating transcription
factors, including Twist, Snail, Zeb1, and Zeb2, can be modulated
by NF-kB under some specific conditions [26], so that it is
plausible that the NF-kB activation resulting from hypoxia or
overexpression of HIF-1a represents a unifying biochemical event
that accounts for the EMT observed in pancreatic cancer cells.
In conclusion, these results should provide incentives for further
investigation and optimization in establishing the mechanistic role
of HIF-1a and NF-kB in the attenuation of EMT characteristics
and drug resistance and their utility in the clinical setting for the
treatment of pancreatic cancer for which there is no effective and
curative therapy.
Materials and Methods
Cell lines and reagents
The human pancreatic cancer cell lines BxPC-3 and PANC-1
were obtained from the American Type Culture Collection
(Rockville, Maryland, USA). Both cell lines were routinely
cultured at 37uC in RPMI 1640 medium supplemented with
Figure 6. NF-kB blockade reverses the EMT driven by the HIF-1a. (A) Western blot analysis of levels of indicated proteins in PANC-1 cells
transduced with pcDNA3.0 empty vector (pcDNA3.0/N) and pcDNA3.0/HIF-1a (HIF-1a
+/N) under normoxic conditions for 48 h. The histogram showed
the average volume density corrected for the loading control (b-actin). *, p,0.05. (B) EMT phenotype changes was confirmed with
Immuofluorescence microscopy staining of E-cadherin and Vimentin. Green represents E-cadherin staining, whereas red represents Vimentin
staining. Blue signal represents nuclear DNA staining by DAPI. (C) Western blot analysis. Dose-dependent effects of a 48-h exposure to the IKK
inhibitor BAY 11-7082 on the indicated proteins. The histogram showed the average volume density corrected for the loading control (b-actin). (D)
Matrigel invasion assays. Effects of a 48-h BAY 11-7082 (10 mmol/L) on invasion of PANC-1 cells under normoxic conditions. Left, photomicrographs at
original magnification of 6100; Right, histogram to illustrate invasion assay results. *, p,0.05. (E) Crystal violet assay. Effects of a 48-h BAY 11-7082
(10 mmol/L) on gemcitabine susceptibility of PANC-1 cells under normoxic conditions. Figures were selected as representative scenes from three
independent experiments. (F) The Effects of IKK inhibitor on gemcitabine susceptibility of PANC-1 cells under normoxic conditions was also measured
by Cell Counting Kit-8 assay and used to calculate the viability index. *, p,0.05.
doi:10.1371/journal.pone.0023752.g006
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(100 mg/ml) in an incubator with 95% air and 5% CO2. Hypoxic
cells were incubated in the same conditions but in a hypoxic
incubator (Precision Scientific, Winchester, VA, USA) with 1%
O2,5 %C O 2, and 94% N2. The IKK inhibitor BAY 11-7082 was
purchased from Merck Biosciences and diluted in culture medium
to obtain the desired concentration. The antibodies against NF-kB
p65, Snail (H-130), Twist (H-81), Zeb-1, Zeb2 and b-actin were
purchased from Santa Cruz Biotechnology Inc., CA, USA. The
HIF-1a Ab was purchased from Abcam Inc., MA, USA. The
Vimentin, E-cadherin and N-cadherin Ab were purchased from
ZSGB-BIO Inc., Beijing, China. Gemcitabine was purchased from
Lily France, Fegersheim, France. Cell Counting Kit-8 (Dojin
Laboratory, Kumamoto, Japan). Endofree Plasmid Maxi Kit
(Qiagen, chatsworth, CA). LipofectamineTM 2000 and Plus
reagent (Invitrogen).
Assessment of cellular morphological changes and
determination of cell viability
Cellular morphology was evaluated using phase-contrast
microscopy, and photographs were captured with a digital camera
(Canon Power shot A640). Cell viability was determined by the
Cell Counting Kit-8 assay and Crystal violet assay. a) Cell
Counting Kit-8 assay: BxPC-3 (4610
3/well) and PANC-1
(3610
3/well) cells were split into 96-well plates and incubated
overnight in a humidified CO2 incubator (95% air and 5% CO2)
to allow the cells to adhere and assume a healthy condition, and
then exposed to gradient doses of gemcitabine (0–200 mmol/L) for
48 h under hypoxic or normoxic conditions. The cells were then
incubated with WST-8 solution at 37uC for 1 h and the
absorbance at 450 nm was measured on a microplate reader
(MPR-A4i, Tosoh Corporation, Tokyo, Japan). The cells cultured
in RPMI 1640 medium served as the control. The cell viability
index was calculated according to the formula: experimental OD
value/control OD value6100%. All experiments were done in
triplicate and repeated thrice. Two cell lines underwent the same
procedure. b) Crystal violet assay: cells (5610
4/well) were seeded
into 6-well plates and cultured overnight. Then the medium was
replaced with complete culture medium containing gemcitabine
(10 mmol/L for PANC-1 and 500 nmol/L for BxPC-3) for
additional 48 h under hypoxic or normoxic conditions. Cells were
then washed twice with pre-warmed PBS, and then cells remaining
were stained for 1 h with a crystal violet solution (0.1% crystal
violet, 20% methanol). After removal of the crystal violet solution,
the plates were washed three times by immersion in a beaker filled
with tap water. Plates were left to dry at 37uC, and then the images
were photographed by camera.
Matrigel invasion assay
The Matrigel invasion assay was performed according to the
manufacturer’s instructions. Each well was coated freshly with
Matrigel (60 mg; BD Bioscience) before the invasion assay. Briefly,
1610
5 cells were plated in the top chamber onto the Matrigel
coated Membrane (24-well insert; pore size, 8 mm; Corning
Costar). Cells were added to the Transwell insert in 0.5 mL of
medium containing 1% fetal bovine serum (FBS), which was
seated in 750 mL of complete medium (10% FBS) with or without
the IKK inhibitor BAY 11-7082 (10 mmol/L). After a 48 h
incubation under hypoxic or normoxic conditions, noninvading
cells were mechanically removed by a cotton swab. Cells that had
migrated through the Matrigel were stained with crystal violet.
Cells were counted in five representative microscopic fields (6100
magnification) and photographed.
Transient transfection and RNA interference
The human pcDNA3.0/HIF-1a (a gift from Max Gassmann
PhD, Institute of Veterinary Biochemistry and Molecular Biology,
University of Zurich, Zurich, Switzerland) were purified in large
scale using the EndoFree Plasmid Maxi kit for transfection. The
human pancreatic cancer cells were transiently transfected with an
pcDNA3.0/HIF-1a, or empty vector (pcDNA3.0) as control using
LipofectamineTM 2000 and Plus reagent in 6 or 12 well plates.
The transfections were performed according to the manufacturer’s
instructions. After transfection, cells were treated as design under
normoxic conditions and then harvested for the following
experiments.
To knock-down NF-kB p65 subunit, synthesized siRNAs duplex
were obtained from Invitrogen. A double-strand siRNA (p65
siRNA), (sense, 59-GCC CUA UCC CUU UAC GUC A-39,
antisense 59-UGA CGU AAA GGG AUA GGG C-39) with two
introduced thymidine residues at the 39 end, which encoded
amino acid residues 347 and 353 of the NF-kB p65 subunit was
designed to target the NF-kB p65 subunit as described previously
[25]. A nonspecific control siRNA (sense, 59-UUC UCC GAA
CGU GUC ACG U-39; antisense 59-ACG UGA CAC GUU
CGG AGA A-39) was also designed. BxPC-3 and PANC-1 cells
were grown to 50% confluence in 6-well plates, and transfected
with the siRNAs in serum-free medium without antibiotic
supplements using LipofectamineTM 2000. Cells were allowed
to stabilize for 12 h before being used in experiments. Silencing of
protein expression was confirmed by Western blot analysis.
Immunofluorescence staining
After designated treatment, BxPC-3 and PANC-1 cells were
fixed with 4% paraformaldehyde for 10 min, permeabilized in
0.5% Triton X-100 for 10 min, and incubated in PBS and 10%
goat serum blocking solution for 1 h. Fixed cells were incubated
for 2 h with Mouse anti-human-E-cadherin, Rabbit anti-human-
Vimentin, in 5% goat serum. Cells were washed and incubated
with Goat anti-mouse FITC (green) or Goat anti-rabbit RBITC
(red) IgG antibody (ZSGB-BIO Inc., Beijing, China) diluted 1:100
in blocking buffer for 1 h. Nuclei were stained with DAPI for
0.5 h. Cells were examined with a fluorescent microscope
equipped with narrow band-pass excitation filters to individually
select for green, red, and blue fluorescence. Cells were observed
through a Canon Power shot A640 camera mounted on
Fluorescent microscope (Nikon, Japan). Experiment was repeated
thrice.
Electrophoretic mobility shift assay (EMSA)
NF-kB activity was measured by EMSA as we have previously
described [25]. The sequences of the oligonucleotides used for the
EMSA are as follows: NF-kB, 59-AGT TGA GGG GAC TTT
CCC AGG C-39 (wild-type) and 59-AGT TGA GGC GAC TTT
CCC AGG C-39(mutant). EMSA was performed by incubating
10 mg of nuclear protein with Gel Shift Binding buffer and 1 mgo f
poly (deoxyinosinic-deoxycytidylic acid) at 4uC for 30 min, and
then mixed with biotin-labeled oligonucleotide bio-NF-kB probe
at room temperature for 20 min, according to the manufacturer’s
instructions (Viagene, Beijing, China). The resulting DNA-protein
complex was separated from free oligonucleotide on a 4%
polyacrylamide gel containing 0.256TBE (Tris/borate/EDTA)
buffer. The dried gels were visualized with a CoolImager imaging
system (IMGR002), and radioactive bands were quantified using
Scion Image software. To check if the observed shifted bands are
specific for NF-kB by competition tests using unlabeled wild-type
NF-kB or mutant NF-kB probes, nuclear extracts were incubated
with 50-fold molar excess of unlabeled probes before the addition
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shifted bands, additionally to the labeled NF-kB probe a
nonlabeled (‘‘cold’’) oligonucleotide is added in excess. If the
observed signals are NF-kB specific, those signals should disappear
in the presence of the cold NF-kB wild-type competitor but should
be unaffected in the presence of the cold ‘‘mutant’’ competitor.
Western blotting
The methodology has been described previously [18]. Briefly,
5610
5 cells were sonicated in RIPA buffer and homogenized.
Debris was removed by centrifugation at 12,000 g for 10 min at
4uC. The samples containing 50 mg protein were electrophoresed
on polyacrylamide SDS gels, and transferred to polyvinylidene
difluoride (PVDF) membranes. The membranes were blocked
with 3% BSA, incubated with primary antibodies, and subse-
quently with alkaline phosphatase-conjugated secondary antibody.
They were developed with 5-bromo-4-chloro-3-indolyl phos-
phate/nitro blue tetrazolium (Tiangen Biotech Co. Ltd., Beijing,
China). Blots were also stained with anti-b-actin Ab as internal
control for the amounts of target proteins.
Statistical analysis
The results were expressed as mean values 6 standard
deviation, and a Student’s t test was used to evaluate statistical
significance. A value of less than 0.05 (p,0.05) was used for
statistical significance.
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